Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.03 – $0.07
18% from low
Exchange
OTC Link
OS
Borrow rate
0.48%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.3K | $0 | $690.7K | $3.4M | $4.4M | $8.2M | $12.5M | $11.3M |
| Cost of revenue | $17.6K | $494.5K | $736.9K | $4.2M | $3.7M | $5.9M | $8.7M | $9.3M |
| Gross profit | −$7.4K | −$494.5K | −$46.2K | −$855.0K | $661.2K | $2.3M | $3.7M | $1.9M |
| Gross margin | -71.5% | — | -6.7% | -25.3% | 15.0% | 28.2% | 30.0% | 17.2% |
| R&D | $0 | $5.4K | $251.8K | $37.6K | $10.6K | $132.3K | $287.1K | $229.2K |
| Operating income | $8.3K | −$7.7M | −$5.9M | −$4.2M | −$2.2M | $542.3K | −$1.5M | −$340.0K |
| EBITDA | −$1.7M | −$6.2M | −$5.0M | −$3.8M | −$2.1M | $1.0M | −$749.5K | $612.6K |
| Net income | −$279.3K | −$8.7M | −$6.0M | −$5.4M | −$3.5M | $223.3K | −$1.4M | −$163.2K |
| Net margin | -2714.2% | — | -862.0% | -159.4% | -79.1% | 2.7% | -11.5% | -1.4% |
| EPS (diluted) | -0.09 | -0.10 | -0.05 | -0.04 | -0.03 | 0.00 | -0.01 | 0.00 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $37M | $0.00 | $0.00–$0.00 | 0 |
| 2027 | $131M | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
NEXTLEAF SOLUTIONS LTD
No one on the platform currently holds OILFF.
No tracked institution reports a position in OILFF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2019-03-11 | 1-for-3.5reverse |
No one on the platform has traded OILFF yet.
| $4M |
| — |
| CNFHFCanaFarma Hemp Products Corp. | $0.00 | +0.00% | $19561 | — |
| CRRTFCrescita Therapeutics, Inc. | $0.56 | +0.00% | $10M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.5× sales vs its 0.9× historical median P/S.
Fair value ≈ $0.07 · price $0.04 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
https://nfne.ws/299620 $OILFF @nextleaf_oils #Biotech #Cannabis #Export #lifescience #Profitable #Chemicals #Pharmaceutical #Biotechnology
View on StockTwits ↗$OILFF reaping rewards as US Legal troubles (Federal RICO suit) has MJ money shifting north of the border. Canada capturing European export $$$ (53% of Germany's Q1 medical market). $CGC, $SNDL, $TLRY
View on StockTwits ↗https://nfne.ws/296103 $OILFF @nextleaf_oils #AGM #BioTech #Cannabis #Export #MicroCap #Chemicals #Pharmaceutical #Biotechnology #Marijuana
View on StockTwits ↗$OILFF $MSOS $YOLO surprised not many cannabis investors are buying OILFF. It’s a hidden gem 💎.
View on StockTwits ↗https://nfne.ws/293358 $OILFF @nextleaf_oils #Cannabis #Distribution #Export #Manufacturing #Technology #Chemicals #Pharmaceutical #Biotech
View on StockTwits ↗https://nfne.ws/286099 $OILFF @nextleaf_oils #Cannabis #CannabisStocks #Earnings #QuarterlyResults #SmallCap #Chemicals #Pharmaceutical #Bi
View on StockTwits ↗Nextleaf Solutions (OTCQB: $OILFF) is scaling its Canadian cannabis CPG platform by appointing Kindred Canada as its national sales agency and adding new distribution partners in Manitoba and Saskatchewan to drive margin-focused brand growth for Glacial Gold, Yard Cannabis, and more. https://prismmarketview.com/nextleaf-solutions-expands-national-commercial-platform-to-accelerate-cpg-brand-growth/
View on StockTwits ↗https://nfne.ws/284504 $OILFF @nextleaf_oils #Cannabis #CBD #extraction #OILS #THC #Chemicals #Pharmaceutical #Biotechnology #Marijuana #Ma
View on StockTwits ↗https://nfne.ws/283825 $OILFF @nextleaf_oils #Cannabis #CBD #extraction #OILS #THC #Chemicals #Pharmaceutical #Biotechnology #Marijuana #Ma
View on StockTwits ↗@whatsnipes the company is profitable. They can start buying back shares at this price. Other than that, $OILFF is not a well known stock. Probably most investors have never even heard of it. I discovered this stock when I was looking up IP. That’s what caught my attention. This was before they launched their own product of Glacial Gold. It was trading around .18 before the product. Their catalyst would be same as all cannabis stocks , legalization.
View on StockTwits ↗@WizTrade71 why do you think $OILFF price hasn’t really moved and are there any upcoming catalysts? How long do you foresee that price target coming to fruition
View on StockTwits ↗@whatsnipes yes, I was, I was also in $DAVE too when it was $5. I sold $ABAT while back for some profit. Only one that I held forever is $OILFF.
View on StockTwits ↗$OILFF positive cash flow, PE 3. MC $6.6m. Revenue $14M. Over 100 patents worldwide. The IP itself is worth more than the MC. $MSOS $YOLO
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.